Steatosis and hepatic expression of genes regulating lipid metabolism in Japanese patients infected with hepatitis C virus

Journal of Gastroenterology

Volumn 45, Issue 1, 2010, Pages 95-104

  Yasui, Kohichiroh ^a   Harano, Yuichi ^a   Mitsuyoshi, Hironori ^a   Tsuji, Kazuhiro ^a   Endo, Mio ^a   Nakajima, Tomoaki ^a   Minami, Masahito ^a   Itoh, Yoshito ^a   Zen, Yoh ^b   Nakanuma, Yasuni ^c   Yoshikawa, Toshikazu ^a   Okanoue, Takeshi ^a,d  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

^c KANAZAWA UNIVERSITY   (Japan)

^d Saiseikai Imperial Gift Foundation Inc Saiseikai Suita Hospital   (Japan)

Author keywords

Fibrosis; Gene expression; Hepatitis C virus; Peroxisome proliferator activated receptor ; Steatosis

Indexed keywords

GAMMA GLUTAMYLTRANSFERASE; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BODY MASS; CONTROLLED STUDY; DISEASE ASSOCIATION; FATTY ACID OXIDATION; FATTY LIVER; FEMALE; FIBROSIS; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GENE EXPRESSION REGULATION; GENE FUNCTION; GENETIC REGULATION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; JAPANESE; LIPID DEGRADATION; LIPID TRANSPORT; LIPOGENESIS; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; FATTY LIVER; FEMALE; GENE EXPRESSION REGULATION; HEPATITIS C; HUMANS; JAPAN; LIPID METABOLISM; LIVER; MALE; MIDDLE AGED; PPAR ALPHA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK FACTORS; RNA, MESSENGER; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; YOUNG ADULT;

EID: 77949272197     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-009-0133-8     Document Type: Article

References (43)

1. T Asselah I Bieche S Narguet A Sabbagh I Laurendeau MP Ripault, et al. 2008 Liver gene expression signature to predict response to pegylated interferon plus ribavirin combination therapy in patients with chronic hepatitis C Gut 57 516 524 10.1136/gut.2007.128611 1:CAS:528:DC%2BD1cXltVKntbk%3D 17895355
2. JM Clark FL Brancati AM Diehl 2002 Nonalcoholic fatty liver disease Gastroenterology 122 1649 1657 10.1053/gast.2002.33573 12016429
3. F Negro 2006 Mechanisms and significance of liver steatosis in hepatitis C virus infection World J Gastroenterol 12 6756 6765 17106922
4. T Poynard J McHutchison M Manns RP Myers J Albrecht 2003 Biochemical surrogate markers of liver fibrosis and activity in a randomized trial of peginterferon alfa-2b and ribavirin Hepatology 38 481 492 10.1053/jhep.2003. 50319 1:CAS:528:DC%2BD3sXmvFSmurs%3D 12883493 (Pubitemid 36919870)
5. G Leandro A Mangia J Hui P Fabris L Rubbia-Brandt G Colloredo, et al. 2006 Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data Gastroenterology 130 1636 1642 10.1053/j.gastro.2006.03.014 16697727
6. S Mihm A Fayyazi H Hartmann G Ramadori 1997 Analysis of histopathological manifestations of chronic hepatitis C virus infection with respect to virus genotype Hepatology 25 735 739 10.1002/hep.510250340 1:STN:280: DyaK2s3gtFCnsw%3D%3D 9049227 (Pubitemid 27106462)
7. L Rubbia-Brandt R Quadri K Abid E Giostra PJ Malé G Mentha, et al. 2000 Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3 J Hepatol 33 106 115 10.1016/S0168-8278(00)80166-X 1:CAS:528: DC%2BD3cXltV2rtLc%3D 10905593 (Pubitemid 30418941)
8. D Kumar GC Farrell C Fung J George 2002 Hepatitis C virus genotype 3 is cytopathic to hepatocytes: reversal of hepatic steatosis after sustained therapeutic response Hepatology 36 1266 1272 10.1053/jhep.2002.36370 12395339 (Pubitemid 35253445)
9. A Monto J Alonzo JJ Watson C Grunfeld TL Wright 2002 Steatosis in chronic hepatitis C: relative contributions of obesity, diabetes mellitus, and alcohol Hepatology 36 729 736 10.1053/jhep.2002.35064 12198667 (Pubitemid 34977185)
10. G Barba F Harper T Harada M Kohara S Goulinet Y Matsuura, et al. 1997 Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets Proc Natl Acad Sci USA 94 1200 1205 10.1073/pnas.94.4.1200 1:CAS:528:DyaK2sXhtlGms74%3D 9037030 (Pubitemid 27087828)
11. K Moriya H Yotsuyanagi Y Shintani H Fujie K Ishibashi Y Matsuura, et al. 1997 Hepatitis C virus core protein induces hepatic steatosis in transgenic mice J Gen Virol 78 1527 1531 1:CAS:528:DyaK2sXktlWlt78%3D 9225025
12. G Perlemuter A Sabile P Letteron G Vona A Topilco Y Chrétien, et al. 2002 Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viral-related steatosis FASEB J 16 185 194 10.1096/fj.01-0396com 1:CAS:528:DC%2BD38XhsVCgsbg%3D 11818366 (Pubitemid 34113012)
13. S Mirandola S Realdon J Iqbal M Gerotto F Dal Pero G Bortoletto, et al. 2006 Liver microsomal triglyceride transfer protein is involved in hepatitis C liver steatosis Gastroenterology 130 1661 1669 10.1053/j.gastro.2006.02.035 1:CAS:528:DC%2BD28Xls1Wisbc%3D 16697730 (Pubitemid 43668848)
14. AI Su JP Pezacki L Wodicka AD Brideau L Supekova R Thimme, et al. 2002 Genomic analysis of the host response to hepatitis C virus infection Proc Natl Acad Sci USA 99 15669 15674 10.1073/pnas.202608199 1:CAS:528:DC%2BD3sXjvFSj 12441396 (Pubitemid 35403989)
15. KH Kim SP Hong K Kim MJ Park KJ Kim J Cheong 2007 HCV core protein induces hepatic lipid accumulation by activating SREBP1 and PPARgamma Biochem Biophys Res Commun 355 883 888 10.1016/j.bbrc.2007.02.044 1:CAS:528: DC%2BD2sXivVagsrg%3D 17331464 (Pubitemid 46366910)
16. T Tsutsumi T Suzuki T Shimoike R Suzuki K Moriya Y Shintani, et al. 2002 Interaction of hepatitis C virus core protein with retinoid X receptor alpha modulates its transcriptional activity Hepatology 35 937 946 10.1053/jhep.2002.32470 1:CAS:528:DC%2BD38XjtFSksbc%3D 11915042 (Pubitemid 34258390)
17. A Yamaguchi S Tazuma T Nishioka W Ohishi H Hyogo S Nomura, et al. 2005 Hepatitis C virus core protein modulates fatty acid metabolism and thereby causes lipid accumulation in the liver Dig Dis Sci 50 1361 1371 10.1007/s10620-005-2788-1 1:CAS:528:DC%2BD2MXmtlCku7w%3D 16047488 (Pubitemid 41184770)
18. Y Cheng S Dharancy M Malapel P Desreumaux 2005 Hepatitis C virus infection down-regulates the expression of peroxisome proliferator-activated receptor alpha and carnitine palmitoyl acyl-CoA transferase 1A World J Gastroenterol 11 7591 7596 1:CAS:528:DC%2BD28Xhs1Kls7k%3D 16437683
19. S Dharancy M Malapel G Perlemuter T Roskams Y Cheng L Dubuquoy, et al. 2005 Impaired expression of the peroxisome proliferator-activated receptor alpha during hepatitis C virus infection Gastroenterology 128 334 342 10.1053/j.gastro.2004.11.016 1:CAS:528:DC%2BD2MXitVemsLk%3D 15685545 (Pubitemid 40431087)
20. Japan Society for the Study of Obesity. New criteria of obesity (in Japanese). J Jpn Soc Study Obes. 2000;6:18-28.
21. P Simmonds A Alberti HJ Alter F Bonino DW Bradley C Brechot, et al. 1994 A proposed system for the nomenclature of hepatitis C viral genotypes Hepatology 19 1321 1324 10.1002/hep.1840190538 1:STN:280:DyaK2c3ivFOksg%3D%3D 8175159
22. VJ Desmet M Gerber JH Hoofnagle M Manns PJ Scheuer 1994 Classification of chronic hepatitis: diagnosis, grading and staging Hepatology 19 1513 1520 10.1002/hep.1840190629 1:STN:280:DyaK2c3ksFWisw%3D%3D 8188183
23. EM Brunt CG Janney AM Di Bisceglie BA Neuschwander-Tetri BR Bacon 1999 Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions Am J Gastroenterol 94 2467 2474 10.1111/j.1572-0241.1999. 01377.x 1:STN:280:DyaK1MvhtFyisw%3D%3D 10484010 (Pubitemid 29420675)
24. JH Lefkowitch ER Schiff GL Davis RP Perrillo K Lindsay HC Bodenheimer Jr, et al. 1993 Pathological diagnosis of chronic hepatitis C: a multicenter comparative study with chronic hepatitis B. The Hepatitis Interventional Therapy Group Gastroenterology 104 595 603 1:STN:280:DyaK3s7ks1aquw%3D%3D 8425703
25. A Lonardo P Loria LE Adinolfi N Carulli G Ruggiero 2006 Hepatitis C and steatosis: a reappraisal J Viral Hepat 13 73 80 10.1111/j.1365-2893.2005.00669.x 1:STN:280:DC%2BD28%2FltFSltQ%3D%3D 16436124
26. N Akuta F Suzuki A Tsubota Y Suzuki T Someya M Kobayashi, et al. 2002 Efficacy of interferon monotherapy to 394 consecutive naive cases infected with hepatitis C virus genotype 2a in Japan: therapy efficacy as consequence of tripartite interaction of viral, host and interferon treatment-related factors J Hepatol 37 831 836 10.1016/S0168-8278(02)00301-X 1:CAS:528:DC%2BD38XoslCjtbs%3D 12445425 (Pubitemid 35404223)
27. K Ohata K Hamasaki K Toriyama K Matsumoto A Saeki K Yanagi, et al. 2003 Hepatic steatosis is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C virus infection Cancer 97 3036 3043 10.1002/cncr.11427 12784339 (Pubitemid 36676258)
28. H Fujie H Yotsuyanagi K Moriya Y Shintani T Tsutsumi T Takayama, et al. 1999 Steatosis and intrahepatic hepatitis C virus in chronic hepatitis J Med Virol 59 141 145 10.1002/(SICI)1096-9071(199910)59:2<141::AID-JMV3>3.0. CO;2-5 1:STN:280:DyaK1MzovFOruw%3D%3D 10459147 (Pubitemid 29407272)
29. L Castera P Chouteau C Hezode ES Zafrani D Dhumeaux JM Pawlotsky 2005 Hepatitis C virus-induced hepatocellular steatosis Am J Gastroenterol 100 711 715 10.1111/j.1572-0241.2005.40898.x 15743372 (Pubitemid 40487573)
30. J Westin H Nordlinder M Lagging G Norkrans R Wejstål 2002 Steatosis accelerates fibrosis development over time in hepatitis C virus genotype 3 infected patients J Hepatol 37 837 842 10.1016/S0168-8278(02)00299-4 12445426 (Pubitemid 35404224)
31. HM Patton K Patel C Behling D Bylund LM Blatt M Vallée, et al. 2004 The impact of steatosis on disease progression and early and sustained treatment response in chronic hepatitis C patients J Hepatol 40 484 490 10.1016/j.jhep.2003.11.004 15123364 (Pubitemid 38230851)
32. L Fartoux O Chazouillères D Wendum R Poupon L Serfaty 2005 Impact of steatosis on progression of fibrosis in patients with mild hepatitis C Hepatology 41 82 87 10.1002/hep.20519 15690484 (Pubitemid 40066385)
33. LE Adinolfi M Gambardella A Andreana MF Tripodi R Utili G Ruggiero 2001 Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity Hepatology 33 1358 1364 10.1053/jhep.2001.24432 1:STN:280:DC%2BD3MzhvFajsA%3D%3D 11391523 (Pubitemid 32496971)
34. E Ikai R Honda Y Yamada 1994 Serum gamma-glutamyl transpeptidase level and blood pressure in nondrinkers: a possible pathogenetic role of fatty liver in obesity-related hypertension J Hum Hypertens 8 95 100 1:STN:280: DyaK2c3mslyhtw%3D%3D 7911531
35. DS Lee JC Evans SJ Robins PW Wilson I Albano CS Fox, et al. 2007 Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart Study Arterioscler Thromb Vasc Biol 27 127 133 10.1161/01.ATV.0000251993.20372.40 1:CAS:528:DC%2BD28XhtlSrsb%2FO 17095717 (Pubitemid 46360389)
36. IJ Perry SG Wannamethee AG Shaper 1998 Prospective study of serum gamma-glutamyltransferase and risk of NIDDM Diabetes Care 21 732 737 10.2337/diacare.21.5.732 1:STN:280:DyaK1c3ltFWhtg%3D%3D 9589232 (Pubitemid 28487063)
37. A de Gottardi V Pazienza P Pugnale F Bruttin L Rubbia-Brandt CE Juge-Aubry, et al. 2006 Peroxisome proliferator-activated receptor-alpha and -gamma mRNA levels are reduced in chronic hepatitis C with steatosis and genotype 3 infection Aliment Pharmacol Ther 23 107 114 10.1111/j.1365-2036.2006. 02729.x 16393287 (Pubitemid 43381173)
38. B Desvergne W Wahli 1999 Peroxisome proliferator-activated receptors: nuclear control of metabolism Endocr Rev 20 649 688 10.1210/er.20.5.649 1:CAS:528:DyaK1MXmvFalsLo%3D 10529898
39. K Moriya K Nakagawa T Santa Y Shintani H Fujie H Miyoshi, et al. 2001 Oxidative stress in the absence of inflammation in a mouse model for hepatitis C virus-associated hepatocarcinogenesis Cancer Res 61 4365 4370 1:CAS:528:DC%2BD3MXktlSqu7o%3D 11389061
40. M Okuda K Li MR Beard LA Showalter F Scholle SM Lemon, et al. 2002 Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein Gastroenterology 122 366 375 10.1053/gast.2002.30983 1:CAS:528:DC%2BD38XhsVGns7o%3D 11832451
41. H Lerat M Honda MR Beard K Loesch J Sun Y Yang, et al. 2002 Steatosis and liver cancer in transgenic mice expressing the structural and nonstructural proteins of hepatitis C virus Gastroenterology 122 352 365 10.1053/gast.2002. 31001 1:CAS:528:DC%2BD38XhsVGns70%3D 11832450
42. MM Lai 2002 Hepatitis C virus proteins: direct link to hepatic oxidative stress, steatosis, carcinogenesis and more Gastroenterology 122 568 571 10.1053/gast.2002.31474 11832470
43. T Asselah L Rubbia-Brandt P Marcellin F Negro 2006 Steatosis in chronic hepatitis C: why does it really matter? Gut 55 123 130 10.1136/gut.2005.069757 1:STN:280:DC%2BD28%2FgtlOiug%3D%3D 16344578 (Pubitemid 41820647)